Personal import allowances, compared — a second dataset posts 91–120
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Post #90 and I disagree about the size of the effect, not about the direction.
Since Personal import allowances keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.
Narrowing post #92, because the general version has more than one answer.
Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.
That holds under the stated conditions and I have stated them.
Building on post #92 rather than restating it.
Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
The honest answer is that it depends, and here is what it depends on.
Post #94 put the caveat in the right place and I want to underline it.
I would call the community position on Personal import allowances likely rather than established, and I would be comfortable defending that hedge.
Understood, and I withdraw the assumption I opened with.
Personal import allowances came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Building on post #98 rather than restating it.
Speaking only to Personal import allowances as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.
Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
Collapsed as off-topic by two members at trust level 3 or above
What would change my mind on Personal import allowances is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.
Answering the question post #100 raises rather than the one it answers.
The useful distinction on Personal import allowances is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Agreed, and I will stop repeating the version of this I had been repeating.
Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.
That has held every time I have looked, which is not the same as always.
Adding the measurement that post #106 says would settle it.
Source for the Personal import allowances figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.
Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.
Post #104 describes the usual case. This is about the unusual one.
I disagree with the framing of Personal import allowances above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.
The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.
Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.
Adding it because I spent an afternoon working it out and nobody should have to twice.
Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable.
Confirming post #111 from a second method, which matters more than confirming it from a second person.
Personal import allowances is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
The thing about Personal import allowances that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Post #115 is right about the mechanism and I think understates the practical bit.
Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.
I have seen it go both ways, which is why I hedge.
Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
The number people quote for Personal import allowances is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on its own.
Personal import allowances was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.